摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(pyridin-2-yl)ethyl 4-methylbenzenesulfonate | 22320-32-7

中文名称
——
中文别名
——
英文名称
2-(pyridin-2-yl)ethyl 4-methylbenzenesulfonate
英文别名
2-(2-pyridyl)ethyl tosylate;2-(2-pyridinyl)-ethyl 4-methylbenzenesulfonate;Toluene-4-sulfonic acid 2-pyridin-2-yl-ethyl ester;2-pyridin-2-ylethyl 4-methylbenzenesulfonate
2-(pyridin-2-yl)ethyl 4-methylbenzenesulfonate化学式
CAS
22320-32-7
化学式
C14H15NO3S
mdl
——
分子量
277.344
InChiKey
BGJNKHGRYOEWMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    438.6±33.0 °C(Predicted)
  • 密度:
    1.236±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    64.6
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:aa155ff78759f60c3c2c0d66f154e285
查看

反应信息

  • 作为反应物:
    描述:
    2-(pyridin-2-yl)ethyl 4-methylbenzenesulfonate 在 lithium bromide 作用下, 以 丙酮 为溶剂, 反应 41.0h, 生成 2-(2-bromoethyl)-1-methylpyridinium iodide
    参考文献:
    名称:
    E1cb 和 E2 消除反应机制之间边界区域的证据:吡啶环激活系统的联合实验和理论研究
    摘要:
    我们报告了一项联合实验和理论研究,以表征由吡啶环激活的系统中碱诱导的 β-消除反应的机制,具有卤素离去基团。研究的系统代表了临界情况,其中不确定反应是通过碳负离子中间体(E1cb,A(xh)D(H)+ D(N))还是通过质子和卤化物的协同损失(E2, A(N)D(E)D(N)) 基础攻击。实验上,在 OD(-)/D(2)O 与非消除底物(1-甲基-2-(2-X 乙基)碘化吡啶)中,H/D 交换的 Taft 相关性用于预测与 N-甲基化底物和 F、Cl、Br 作为离去基团的消除反应的速率常数。比较表明 E1cb 不可逆机制与 F,但是用 Cl 和 Br 观察到的偏差不允许得出结论性的分配。理论计算表明,对于具有氟化物离去基团的 N-甲基化底物,通过形成中等稳定的碳负离子进行消除。当离去基团是 Cl 或 Br 以及任何非甲基化物质时,没有发现稳定的阴离子中间体,表明协同消除。然而,尽管机制发生了变化,但与氟化底物相比,含
    DOI:
    10.1021/ja0539138
  • 作为产物:
    描述:
    2-羟乙基吡啶对甲苯磺酰氯吡啶 作用下, 以78%的产率得到2-(pyridin-2-yl)ethyl 4-methylbenzenesulfonate
    参考文献:
    名称:
    Synthesis, structures of (aminopyridine)nickel complexes and their use for catalytic ethylene polymerization
    摘要:
    一系列α-氨基吡啶类化合物(2,6-C6H3N)(R1)(CHR2NR3R4)(R1 = R2 = H, R3 = H, R4 = iPr (L1a), R4 = tBu (L1b), R4 = Ph (L1c), R4 = 2,6-Me2C6H3 (L1d), R4 = 2,6-iPr2C6H3 (L1e), R1 = R2 = H, R3 = R4 = Et (L1f), R1 = H, R2 = Me, R3 = H, R4 = iPr (L2a), R4 = Ph (L2c), R4 = 2,6-Me2C6H3 (L2d), R4 = 2,6-iPr2C6H3 (L2e), R1 = Me, R2 = H, R3 = H, R4 = 2,6-iPr2C6H3 (L3e))和β-氨基吡啶类化合物(2-C6H4N)(CH2CH2NR1R2)(R1 = H, R2 = iPr (4a), R2 = tBu (L4b), R1 = R2 = Et (L4f))已被合成。通过配体取代反应从(DME)NiBr2合成相应的卤化镍配合物1a–4f,并由X射线晶体学表征其分子结构。通过X射线结晶学确定了四种配位模式,包括单核四配位物种与一个配体、单核五配位物种与两个配体、双核五配位物种与两个配体以及六配位的聚合框架。使用甲基铝氧烷(MAO)作为活化剂,镍配合物可以在中等压力和室温下催化乙烯聚合。活性达到105 g PE mol−1 Ni h。具有高度支化和高度结晶性的PE产品,Mn ∼ 103,PDI < 2。
    DOI:
    10.1039/c2dt30151b
点击查看最新优质反应信息

文献信息

  • Synthesis, structures of (aminopyridine)nickel complexes and their use for catalytic ethylene polymerization
    作者:Ya-Chi Lin、Kuo-Hsuan Yu、Ya-Fan Lin、Gene-Hsiang Lee、Yu Wang、Shiuh-Tzung Liu、Jwu-Ting Chen
    DOI:10.1039/c2dt30151b
    日期:——
    A series of α-aminopyridines in the form of (2,6-C6H3N)(R1)(CHR2NR3R4) (R1 = R2 = H R3 = H R4 = iPr (L1a), R4 = tBu (L1b), R4 = Ph (L1c), R4 = 2,6-Me2C6H3 (L1d), R4 = 2,6-iPr2C6H3 (L1e), R1 = R2 = H R3 = R4 = Et (L1f), R1 = H R2 = Me R3 = H R4 = iPr (L2a), R4 = Ph (L2c), R4 = 2,6-Me2C6H3 (L2d), R4 = 2,6-iPr2C6H3 (L2e), R1 = Me R2 = H R3 = H R4 = 2,6-iPr2C6H3 (L3e)) and β-aminopyridines in the form of (2-C6H4N)(CH2CH2NR1R2) (R1 = H R2 = iPr (4a), R2 = tBu (L4b), R1 = R2 = Et (L4f)) have been prepared. Their corresponding halonickel complexes 1a–4f are synthesized by ligand substitution from (DME)NiBr2 and the molecular structures are characterized. Four types of coordination modes include four-coordinate mononuclear species with one ligand, five-coordinate mononuclear species with two ligands, five-coordinate dinuclear species with two ligands, and a six-coordinate polymeric framework were determined by X-ray crystallography. Using methylaluminoxanes (MAO) as the activator, the nickel complexes can catalyze ethylene polymerization under moderate pressure and ambient temperature. The activity reaches 105 g PE mol−1 Ni h. The PE products with high branching and high crystallinity have Mn ∼ 103 with PDI < 2.
    一系列α-氨基吡啶类化合物(2,6-C6H3N)(R1)(CHR2NR3R4)(R1 = R2 = H, R3 = H, R4 = iPr (L1a), R4 = tBu (L1b), R4 = Ph (L1c), R4 = 2,6-Me2C6H3 (L1d), R4 = 2,6-iPr2C6H3 (L1e), R1 = R2 = H, R3 = R4 = Et (L1f), R1 = H, R2 = Me, R3 = H, R4 = iPr (L2a), R4 = Ph (L2c), R4 = 2,6-Me2C6H3 (L2d), R4 = 2,6-iPr2C6H3 (L2e), R1 = Me, R2 = H, R3 = H, R4 = 2,6-iPr2C6H3 (L3e))和β-氨基吡啶类化合物(2-C6H4N)(CH2CH2NR1R2)(R1 = H, R2 = iPr (4a), R2 = tBu (L4b), R1 = R2 = Et (L4f))已被合成。通过配体取代反应从(DME)NiBr2合成相应的卤化镍配合物1a–4f,并由X射线晶体学表征其分子结构。通过X射线结晶学确定了四种配位模式,包括单核四配位物种与一个配体、单核五配位物种与两个配体、双核五配位物种与两个配体以及六配位的聚合框架。使用甲基铝氧烷(MAO)作为活化剂,镍配合物可以在中等压力和室温下催化乙烯聚合。活性达到105 g PE mol−1 Ni h。具有高度支化和高度结晶性的PE产品,Mn ∼ 103,PDI < 2。
  • Copper-Chelating Azides for Efficient Click Conjugation Reactions in Complex Media
    作者:Valentina Bevilacqua、Mathias King、Manon Chaumontet、Marc Nothisen、Sandra Gabillet、David Buisson、Céline Puente、Alain Wagner、Frédéric Taran
    DOI:10.1002/anie.201310671
    日期:2014.6.2
    chelation‐assisted copper catalysis was employed for the development of new azides that display unprecedented reactivity in the copper(I)‐catalyzed azide–alkyne [3+2] cycloaddition (CuAAC) reaction. Azides that bear strong copper‐chelating moieties were synthesized; these functional groups allow the formation of azide copper complexes that react almost instantaneously with alkynes under diluted conditions. Efficient
    螯合辅助铜催化的概念被用于开发新的叠氮化物,这些新叠氮化物在铜(I)催化的叠氮化物-炔烃[3 + 2]环加成(CuAAC)反应中显示出前所未有的反应活性。合成了具有强铜螯合部分的叠氮化物;这些官能团允许形成叠氮化物铜络合物,在稀释条件下,它们几乎可以瞬间与炔烃反应。在低浓度和仅含一当量铜的复杂介质中即可进行有效的连接,从而提高了CuAAC反应的生物相容性。此外,这种点击反应通过荧光测量允许生物活性化合物在活细胞内定位。
  • Opioid ligands with mixed properties from substituted enantiomeric <i>N</i>-phenethyl-5-phenylmorphans. Synthesis of a µ-agonist δ-antagonist and δ-inverse agonists
    作者:Kejun Cheng、In Jong Kim、Mei-Jing Lee、Steven A. Adah、Tyler J. Raymond、Edward J. Bilsky、Mario D. Aceto、Everette L. May、Louis S. Harris、Andrew Coop、Christina M. Dersch、Richard B. Rothman、Arthur E. Jacobson、Kenner C. Rice
    DOI:10.1039/b618875c
    日期:——

    A novel potent non-peptide morphine-like antinociceptive with μ-agonist and δ-antagonist properties represents a lead towards non-dependence producing analgesics.

    一种新型强效非肽形态的类吗啡止痛药物,具有μ-激动剂和δ-拮抗剂特性,可作为不产生依赖性的镇痛药物的前导。
  • Copper-Catalyzed Cross-Coupling of Functionalized Alkyl Halides and Tosylates with Secondary and Tertiary Alkyl Grignard Reagents
    作者:Peng Ren、Lucas-Alexandre Stern、Xile Hu
    DOI:10.1002/anie.201204275
    日期:2012.9.3
    Added value: A copper‐based method is highly efficient for the cross‐coupling of alkyl electrophiles with secondary and tertiary alkyl Grignard reagents. The method is distinguished by its broad substrate scope and high functional group tolerance.
    附加值:铜基方法对于烷基亲电试剂与仲烷基和叔烷基格氏试剂的交叉偶联非常有效。该方法以其广泛的底物范围和高官能团耐受性而著称。
  • Addition/elimination reactions of ethylsulfonyl pyridines: stereoselective synthesis of vinylpyridine allylic alcohols
    作者:Gregory W. O’Neil、Nathan D. Drake、Jennifer M. Storvick
    DOI:10.1016/j.tetlet.2012.12.049
    日期:2013.2
    2-(Phenylsulfonyl)ethyl pyridines can be coupled with aldehydes leading directly to sulfone-eliminated vinylpyridine allylic alcohols. These products are obtained in good yield and with high levels of stereocontrol.
    2-(苯磺酰基)乙基吡啶可以与醛偶联,直接导致砜消除的乙烯基吡啶烯丙基醇。这些产品以高收率和高水平的立体控制获得。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐